Show Search Form
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health and Social Care | ||||||||||
answering dept sort name | Health and Social Care | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Cannabis: Medical Treatments | ||||||||||
house id | 1 | ||||||||||
identifier | 45233 | ||||||||||
legislature |
|
||||||||||
parliament number | 58 | ||||||||||
question first answered |
|
||||||||||
question text | To ask the Secretary of State for Health and Social Care, whether his Department has made an impact assessment of the regulations prohibiting regulated manufacture of medical cannabis and CBD products on patient safety. | ||||||||||
session |
|
||||||||||
session number | 3 | ||||||||||
tabling member constituency | Linlithgow and East Falkirk | ||||||||||
tabling member printed |
|
||||||||||
title | House of Commons Tabled Parliamentary Question 2022/23 45233 | ||||||||||
type |
|
||||||||||
uin | 45233 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | Ordinary | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher | 25259 | ||||||||||
tabling member |
|
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 20 | ||||||||||
answering dept short name | International Development | ||||||||||
answering dept sort name | International Development | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Costa Rica: Coronavirus | ||||||||||
house id | 1 | ||||||||||
identifier | 45233 | ||||||||||
legislature |
|
||||||||||
parliament number | 58 | ||||||||||
question first answered |
|
||||||||||
question text | To ask the Secretary of State for International Development, what assessment she has made of the potential merits of the proposal from the Government of Costa Rica for the World Health Organisation to create a global pool of rights in covid-19 related technologies for the detection, prevention, control and treatment of covid-19. | ||||||||||
session |
|
||||||||||
session number | 1 | ||||||||||
tabling member constituency | Rotherham | ||||||||||
tabling member printed |
|
||||||||||
title | House of Commons Tabled Parliamentary Question 2019/21 45233 | ||||||||||
type |
|
||||||||||
uin | 45233 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | NamedDay | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher | 25259 | ||||||||||
tabling member |
|
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 208 | ||||||||||
answering dept short name | Foreign, Commonwealth and Development Office | ||||||||||
answering dept sort name | Foreign, Commonwealth and Development Office | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Foreign, Commonwealth and Development Office: Redundancy | ||||||||||
house id | 1 | ||||||||||
identifier | 45233 | ||||||||||
legislature |
|
||||||||||
parliament number | 58 | ||||||||||
question first answered |
|
||||||||||
question text | To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, pursuant to the Answer of 6 September 2021 to Question 37556 on Foreign, Commonwealth and Development Office: Redundancy, whether he has plans for compulsory redundancies as a result of factors aside from the merger of FCO and DFID. | ||||||||||
session |
|
||||||||||
session number | 2 | ||||||||||
tabling member constituency | Birmingham, Edgbaston | ||||||||||
tabling member printed |
|
||||||||||
title | House of Commons Tabled Parliamentary Question 2021/22 45233 | ||||||||||
type |
|
||||||||||
uin | 45233 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | NamedDay | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher | 25259 | ||||||||||
tabling member |
|
human indexable | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||
registered interest | |||||||||||
answer date | |||||||||||
date | |||||||||||
date tabled | |||||||||||
ddp created | |||||||||||
answering body |
|
||||||||||
question status | Tabled | ||||||||||
answering dept id | 17 | ||||||||||
answering dept short name | Health | ||||||||||
answering dept sort name | Health | ||||||||||
ddp modified |
|
||||||||||
hansard heading | Cancer: Drugs | ||||||||||
house id | 1 | ||||||||||
identifier | 45233 | ||||||||||
legislature |
|
||||||||||
parliament number | 56 | ||||||||||
question first answered |
|
||||||||||
question text | To ask the Secretary of State for Health, to what extent NICE has involved external stakeholders and charities in reviewing how well the incremental cost effectiveness ratio is working in making new cancer medicines available to patients on the NHS. | ||||||||||
session |
|
||||||||||
session number | 2 | ||||||||||
tabling member constituency | Scunthorpe | ||||||||||
tabling member printed |
|
||||||||||
title | House of Commons Tabled Parliamentary Question 2016/17 45233 | ||||||||||
type |
|
||||||||||
uin | 45233 | ||||||||||
version | 1 | ||||||||||
written parliamentary question type | NamedDay | ||||||||||
answer | answer | ||||||||||
creator |
|
||||||||||
publisher | 25259 | ||||||||||
tabling member |
|